Submitted by Anonymous (not verified) on 22 September 2023 - 10:25
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Abdominal Neoplasms, Date of authorisation: 19/09/2019, Revision: 10, Status: Authorised
Source: